Loading...
BACE2 Expression Increases in Human Neurodegenerative Disease
β-Secretase, the rate-limiting enzymatic activity in the production of the amyloid-β (Aβ) peptide, is a major target of Alzheimer's disease (AD) therapeutics. There are two forms of the enzyme: β-site Aβ precursor protein cleaving enzyme (BACE) 1 and BACE2. Although BACE1 increases in late-stag...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Investigative Pathology
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3338345/ https://ncbi.nlm.nih.gov/pubmed/22074738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2011.09.034 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|